Please assess the completion status of the following clinical trial:

Trial Title: Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with type 2 diabetes who first use Suglat Tablets during the period from July 17, 2014 to July 16, 2015~Exclusion Criteria:~* off-label use patients

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Suglat group (Type: None): Tablets

Based on this trial design, predict the completion outcome and termination type (if applicable).